Nasobec Hayfever (Beclometasone Dipropionate)

Beclometasone dipropionate, the active ingredient in Nasobec Hayfever, is a corticosteroid presented as a nasal formulation for intranasal use. It reduces inflammation in the nasal passages and is indicated for the treatment of allergic rhinitis and hay fever in adults and children, effectively helping to improve nasal airflow.

GNH USA supplies Nasobec Hayfever as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches for global distribution.

Beclometasone dipropionate acts locally in the nasal mucosa to control inflammation associated with allergic airway disease.

- Allergic rhinitis: reduces nasal congestion, sneezing, itching and rhinorrhoea. - Hay fever: alleviates seasonal allergy symptoms affecting the nose and eyes. - Nasal inflammation: decreases inflammatory cell infiltration and cytokine release in the nasal passages.

Adverse reactions are generally localized to the nasal cavity and may vary in frequency.

Common Side Effects: - Nasal irritation: mild burning or stinging sensation. - Dryness of nasal mucosa: feeling of dryness or crusting. - Epistaxis: occasional nosebleeds. - Headache: transient mild headache. - Altered taste: temporary metallic or bitter taste. - Throat irritation: mild soreness or tickle.

Serious or Rare Side Effects: - Fungal infection of nasal mucosa: opportunistic growth requiring medical attention. - Severe epistaxis: prolonged or heavy nosebleeds. - Vision changes: rare cases of blurred vision or cataract progression. - Adrenal suppression: systemic effect with prolonged high‑dose use. - Allergic reaction: rash, swelling or anaphylaxis in susceptible individuals.

Before using Nasobec Hayfever, consider the following safety measures.

- Pregnancy: consult a healthcare professional as safety data are limited. - Breastfeeding: use only if the potential benefit outweighs the risk. - Concomitant infections: monitor for secondary fungal or bacterial infections in the nasal cavity. - Long‑term use: assess periodically for possible adrenal axis suppression. - Ocular conditions: use with caution in patients with glaucoma or cataracts. - Store at room temperature: keep in the original container, protect from moisture and heat.

Beclometasone dipropionate may interact with other medicines that affect corticosteroid activity or nasal flora.

Major Interactions (Avoid): - Systemic corticosteroids: increased risk of systemic glucocorticoid effects. - Strong CYP3A4 inhibitors: may raise local drug exposure and side‑effect potential.

Moderate Interactions (Monitor Closely): - Antihistamines: additive relief of nasal symptoms, monitor for over‑sedation. - Antifungal nasal sprays: possible alteration of local microbial balance. - Live vaccines: consider timing of administration relative to steroid use.